PRESS RELEASE published on 05/06/2024 at 23:25, 11 months 3 days ago Jolt Health To Acquire HCQ Transdermal Patch Technology Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027* Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF published on 03/27/2024 at 21:55, 1 year ago Jolt Health Inc. annonce la clôture du financement Financement Placement Privé Remboursement De Dette Jolt Santé Inc. Fonds De Roulement
BRIEF published on 03/27/2024 at 21:55, 1 year ago Jolt Health Inc. Announces Closing of Financing Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE published on 03/27/2024 at 21:50, 1 year ago Jolt Health Inc. Announces Closing of Financing Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.
BRIEF published on 03/08/2024 at 13:05, 1 year 1 month ago Jolt Health Inc. annonce des expansions stratégiques et des changements au conseil d'administration Santé Et Bien-être Médicaments Jolt Santé Inc. Développement De Médicaments IA Financement Par Placement Privé
BRIEF published on 03/08/2024 at 13:05, 1 year 1 month ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 1 year 1 month ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 2 years 1 month ago Love Pharma Inc. Announces Share Consolidation
Published on 04/10/2025 at 09:30, 12 minutes ago Chow Tai Fook Jewellery Group Celebrates First Anniversary of Brand Transformation
Published on 04/10/2025 at 06:08, 3 hours 34 minutes ago Tocvan Commences Drilling at Gran Pilar Gold - Silver Project Continues Expansion Zone Drilling Along Northern Corridors
Published on 04/10/2025 at 02:30, 7 hours 12 minutes ago Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/09/2025 at 23:30, 10 hours 12 minutes ago AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/10/2025 at 09:24, 17 minutes ago u-blox introduces ANNA-B5: Compact, powerful and secure Bluetooth® LE module
Published on 04/10/2025 at 09:07, 34 minutes ago Chow Tai Fook Jewellery Group Celebrates First Anniversary of Brand Transformation
Published on 04/10/2025 at 09:03, 38 minutes ago EQS-Adhoc: Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 2025 - for the first time more than EUR 10.7 million revenue in one month
Published on 04/10/2025 at 08:52, 50 minutes ago Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 – for the first time more than EUR 10.7 million revenue in one month
Published on 04/09/2025 at 18:59, 14 hours 42 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:59, 14 hours 42 minutes ago Descriptif du programme de rachat d'actions 2025-2026
Published on 04/09/2025 at 18:57, 14 hours 44 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 18:57, 14 hours 44 minutes ago Compte-rendu de l'Assemblée Générale Mixte du 9 avril 2025
Published on 04/09/2025 at 17:45, 15 hours 57 minutes ago COGELEC : Résultats annuels 2024 et Chiffre d’affaires du 1 er trimestre 2025.
